L&C BIO Co.,LTD (KOSDAQ: 290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,720
0.00 (0.00%)
Sep 11, 2024, 2:56 PM KST
-56.85%
Market Cap 377.93B
Revenue (ttm) 72.04B
Net Income (ttm) 49.01B
Shares Out 22.68M
EPS (ttm) 2,120.79
PE Ratio 7.86
Forward PE n/a
Dividend 100.00 (0.60%)
Ex-Dividend Date n/a
Volume 123,516
Open 16,690
Previous Close 16,720
Day's Range 16,650 - 17,220
52-Week Range 16,480 - 39,200
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 11, 2024

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Employees 124
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2023, L&C BIO Co.,LTD's revenue was 68.87 billion, an increase of 31.00% compared to the previous year's 52.57 billion. Earnings were 48.36 billion, an increase of 964.24%.

Financial Statements

News

There is no news available yet.